Skip to content

Self-criticism and self-injury: Testing a novel diary-based treatment approach

Novel online daily diary interventions for non-suicidal self injury: A preliminary study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12276176
Enrollment
144
Registered
2018-03-13
Start date
2015-06-25
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-suicidal self-injury Mental and Behavioural Disorders Intentional self-harm

Interventions

Participants were recruited from online forums related to self-injury and severe psychopathology (e.g. reddit.com/r/depression). Forum members who met the inclusion criteria and were interested in par

Sponsors

The Eric M. Mindich Research Fund for the Foundation of Human Behavior.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. =2 NSSI episodes in previous month 2. Aged 18 years or over 3. Daily internet access 4. Fluent in English

Exclusion criteria

Exclusion criteria: Inclusion criteria not met

Design outcomes

Primary

MeasureTime frame
Primary outcomes were self-criticism, depression, self-cutting episodes, and overall NSSI episodes (including self-cutting). Self-criticism (using the Self-Rating Scale - self-report questionnaire) and depression (using the Beck Depression Inventory-II) were assessed at baseline, week 1, week 2, week 3, and week 4 of treatment, 4 weeks post-treatment and 12 weeks post-treatment.

Secondary

MeasureTime frame
Secondary outcomes were desire to discontinue NSSI, likelihood of future NSSI, days of active suicide ideation, and days of suicide plans. A self-report questionnaire version of the Self-Injurious Thoughts and Behaviors Interview was used to obtain measures of NSSI, suicide ideation, suicide plans, and suicidal behaviors. Each of these thoughts and behaviors were measured at baseline, week 1, week 2, week 3, and week 4 of treatment. These were also measured over two follow-up time points, at 8 and 12 weeks post treatment.

Countries

Australia, Canada, Costa Rica, Germany, Hungary, Ireland, Japan, Netherlands, Portugal, Romania, Russian Federation, Sweden, United Kingdom, United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 5, 2026